Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx

ClinicalTrials.gov ID: NCT00003040

Public ClinicalTrials.gov record NCT00003040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx

Study identification

NCT ID
NCT00003040
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
42 participants

Conditions and interventions

Interventions

  • laser surgery Procedure
  • radiation therapy Radiation

Procedure · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 1997
Primary completion
Jan 31, 2007
Completion
Nov 30, 2007
Last update posted
Jun 14, 2012

1997 – 2007

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90033-0804
University of California Davis Medical Center Sacramento California 95817
University of Colorado Cancer Center Denver Colorado 80010
Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky 40536-0084
University of Mississippi Medical Center Jackson Mississippi 39216-4505
St. Louis University Health Sciences Center St Louis Missouri 63110-0250
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
Oregon Cancer Center Portland Oregon 97201-3098
University of Texas Health Science Center at San Antonio San Antonio Texas 78284-7811
Huntsman Cancer Institute Salt Lake City Utah 84112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003040 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →